Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


1 AIDS Res Hum Retroviruses
1 Ann Neurol
1 Antimicrob Agents Chemother
1 Cancer
3 Clin Infect Dis
3 HIV Med
3 J Acquir Immune Defic Syndr
2 J Infect Dis
1 J Med Virol
4 J Virol
2 Lancet
1 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
17 PLoS One
2 PLoS Pathog
3 Proc Natl Acad Sci U S A
1 Vaccine
1 Virology


  1. STOVER S, Milloy MJ, Grant C, Fairbairn N, et al
    Estimating the minimum antiretroviral adherence required for plasma HIV-1 RNA viral load suppression among people living with HIV who use unregulated drugs.
    AIDS. 2022;36:1233-1243.
    >> Share

  2. CRUM NF, Ahmad A
    Immunity against measles in people with HIV: the need for more research and surveillance.
    AIDS. 2022;36:1305-1306.
    >> Share

  3. POLI G, Stapleton JT
    Sex matters... cytokines and disease progression in men and women receiving combination antiretroviral therapy.
    AIDS. 2022;36:1307-1309.
    >> Share

    Cytomegalovirus: 40 years and still the major viral cofactor in HIV infection.
    AIDS. 2022;36:1311-1313.
    >> Share

  5. WOLDEMESKEL BA, Karaba AH, Garliss CC, Beck EJ, et al
    Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV.
    AIDS. 2022;36:1315-1317.
    >> Share

  6. GIANSERRA L, Dona MG, Giuliani E, Stingone C, et al
    High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?
    AIDS. 2022;36:1319-1320.
    >> Share

  7. BOTTANELLI M, Messina E, Barbera M, Guffanti M, et al
    Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV.
    AIDS. 2022;36:1321-1323.
    >> Share

  8. NEARY J, Mugo C, Wagner A, Ogweno V, et al
    Caregiver fears and assumptions about child HIV status drive not testing children for HIV.
    AIDS. 2022;36:1323-1325.
    >> Share

  9. MICAN R, Grela AG, Cadinanos J, de Miguel R, et al
    Impact of Pre-Existing Nrti Resistance on the Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experience Patients: Real-World Data.
    AIDS. 2022 Jul 8. pii: 00002030-990000000-00052.
    >> Share

  10. HUIK K, Hill S, George J, Pau A, et al
    High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy.
    AIDS. 2022 Jul 11. pii: 00002030-990000000-00033.
    >> Share

  11. VAKILI S, Paneru B, Guerrier CM, Miller J, et al
    Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing ART.
    AIDS. 2022 Jul 8. pii: 00002030-990000000-00054.
    >> Share

  12. PANNEER N, Balaji AB, Crim SM, Bosh KA, et al
    Assessing concordance of HIV risk behaviors collected by different surveillance systems.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00059.
    >> Share

  13. TINCATI C, Ficara M, Ferrari F, Augello M, et al
    Gut-dependent inflammation and alterations of the intestinal microbiota in individuals with perinatal HIV exposure and different HIV serostatus.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00067.
    >> Share

  14. LI G, Park LS, Lodi S, Logan RW, et al
    Tenofovir disoproxil fumarate and COVID-19 outcomes in men with HIV.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00063.
    >> Share

  15. ZHU W, Huang YA, Weiner J, Neblett-Fanfair R, et al
    Impact of the COVID-19 pandemic on prescriptions for antiretroviral drugs for HIV treatment in the United States, 2019-2021.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00062.
    >> Share

  16. BANNISTER WP, Mast TC, de Wit S, Gerstoft J, et al
    Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00070.
    >> Share

  17. MUNGWIRA RG, Laurens MB, Nyangulu W, Divala TH, et al
    High burden of malaria among Malawian adults on antiretroviral therapy after discontinuing prophylaxis.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00064.
    >> Share

  18. WEISER B, Shi B, Kemal K, Burger H, et al
    Long-term antiretroviral therapy mitigates mortality and morbidity independent of HIV tropism: 18 years follow-up in a women's cohort.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00061.
    >> Share

  19. TENG AE, Kennedy KF, Parikh RV, Armstrong EJ, et al
    Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00058.
    >> Share

  20. FOTSO AS, Johnson C, Vautier A, Kouame KB, et al
    Routine programmatic data show a positive population-level impact of HIV self-testing: the case of Cote d'Ivoire and implications for implementation.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00071.
    >> Share

  21. ROUSSET S, Zenou M, Saunier A, Varenne F, et al
    Immune recovery-related patterns of post kala-azar dermal and ocular leishmaniasis in people living with HIV: a national survey and literature review.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00072.
    >> Share

  22. HANSEN ME, Mangusan R, Lurain K, Odeny T, et al
    Characteristics of patients admitted to the intensive care unit with Kaposi sarcoma herpesvirus-associated diseases.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00068.
    >> Share

  23. GIRARDI E, Caro-Vega Y, Cozzi-Lepri A, Musaazi J, et al
    The contribution of late HIV diagnosis on the occurrence of HIV-associated tuberculosis: a 5-year estimate using real-world data.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00065.
    >> Share

  24. ANTE-TESTARD PA, Hamidouche M, Apouey B, Baggaley R, et al
    Understanding the pathways leading to socioeconomic inequalities in HIV testing uptake in 18 sub-Saharan African countries: a mediation analysis.
    AIDS. 2022 Jul 11. pii: 00002030-990000000-00057.
    >> Share

  25. HAU TTT, Nishizawa M, Harada S, Phan MH, et al
    Association of envelope-specific B-cell differentiation and viral selective pressure signatures in HIV-1 CRF01_AE infection.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00066.
    >> Share

  26. RAI MA, Shi V, Kennedy BD, Whitehead EJ, et al
    Effect of aging on immune cells in male HIV-infected and -uninfected healthy individuals.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00069.
    >> Share

  27. HUNT M, Mcniff MM, Vincent AE, Sabin C, et al
    Skeletal muscle mitochondrial dysfunction in contemporary antiretroviral therapy: a single cell analysis.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00060.
    >> Share

  28. MICHEL M, Labenz C, Wahl A, Anders M, et al
    Prevalence and risk factors of non-alcoholic steatohepatitis with significant fibrosis in people living with HIV.
    AIDS. 2022 Jul 8. pii: 00002030-990000000-00053.
    >> Share

  29. ZHAO B, Ding H, Song W, Kang M, et al
    Antiretroviral therapy initiation within 7 days and 8 days-30 days post-HIV diagnosis demonstrates similar benefits in resource-limited settings.
    AIDS. 2022 Jul 11. pii: 00002030-990000000-00056.
    >> Share

  30. PELUSO MJ, Spinelli MA, Deveau TM, Forman CA, et al
    Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection.
    AIDS. 2022 Jul 19. pii: 00002030-990000000-00073.
    >> Share

    AIDS Res Hum Retroviruses

  31. CASSEB J, Lopes LR
    Reflection about the ancient emergence of HTLV-2 infection: Potential for endogenization.
    AIDS Res Hum Retroviruses. 2022 Jul 14. doi: 10.1089/AID.2022.0019.
    >> Share

    Ann Neurol

  32. COCHRANE CR, Angelovich TA, Byrnes SJ, Waring E, et al
    Intact HIV proviruses persist in the brain despite viral suppression with ART.
    Ann Neurol. 2022 Jul 22. doi: 10.1002/ana.26456.
    >> Share

    Antimicrob Agents Chemother

  33. DEVANATHAN AS, White NR, Desyaterik Y, De la Cruz G, et al
    Quantitative Imaging Analysis of the Spatial Relationship between Antiretrovirals, Reverse Transcriptase Simian-Human Immunodeficiency Virus RNA, and Fibrosis in the Spleens of Nonhuman Primates.
    Antimicrob Agents Chemother. 2022 Jul 20:e0060922. doi: 10.1128/aac.00609.
    >> Share


  34. MAZUL AL, Hartman CM, Mowery YM, Kramer JR, et al
    Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans.
    Cancer. 2022 Jul 22. doi: 10.1002/cncr.34387.
    >> Share

    Clin Infect Dis

  35. SEKAGGYA-WILTSHIRE C, Nabisere R, Musaazi J, Otaalo B, et al
    Decreased dolutegravir and efavirenz concentrations with preserved virological suppression in patients with TB and HIV receiving high-dose rifampicin.
    Clin Infect Dis. 2022 Jul 21. pii: 6647783. doi: 10.1093.
    >> Share

  36. LEVIN AE, Bangdiwala AS, Nalintya E, Kagimu E, et al
    Outpatient Cryptococcal Antigen Screening is Associated with Favorable Baseline Characteristics and Improved Survival in Persons with Cryptococcal Meningitis in Uganda.
    Clin Infect Dis. 2022 Jul 21. pii: 6647578. doi: 10.1093.
    >> Share

  37. CHANG C, Agbaji O, Mitruka K, Olatunde B, et al
    Clinical Outcomes in a Randomized Controlled Trial Comparing Point-of-Care Versus Standard HIV Viral Load Monitoring in Nigeria.
    Clin Infect Dis. 2022 Jul 22. pii: 6648552. doi: 10.1093.
    >> Share

    HIV Med

  38. RACCAGNI AR, Bruzzesi E, Calzavara D, Vinti P, et al
    HIV-NAAT use for early detection of HIV infection among high-risk men who have sex with men in Italy.
    HIV Med. 2022 Jul 15. doi: 10.1111/hiv.13363.
    >> Share

  39. TSAKONA D, Kapetanakis A, Kyrou D, Vrontaras N, et al
    Mapping frailty in people living with HIV: A nationwide study in Greece.
    HIV Med. 2022 Jul 15. doi: 10.1111/hiv.13356.
    >> Share

  40. SCHUETTFORT G, Groh A, Kann G, Haberl A, et al
    Sexually transmitted diseases in people living with HIV after implementation of cost coverage of HIV pre-exposure prophylaxis by statutory health insurance in Germany.
    HIV Med. 2022 Jul 20. doi: 10.1111/hiv.13353.
    >> Share

    J Acquir Immune Defic Syndr

  41. BROWN LK, Baltrusaitis K, Kennard BD, Emslie GJ, et al
    Forty-eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth with HIV in the United States.
    J Acquir Immune Defic Syndr. 2022 Jul 15. pii: 00126334-990000000-00081.
    >> Share

  42. WENDT CH, Samorodnitsky S, Lock EF, Kruk M, et al
    The lung and plasma metabolome in HIV-associated obstructive lung disease (OLD).
    J Acquir Immune Defic Syndr. 2022 Jul 15. pii: 00126334-990000000-00080.
    >> Share

  43. TIEOSAPJAROEN W, Fairley CK, Eric CPF, Ivette A, et al
    Preferences for weight gain compared with other antiretroviral therapy side effects in people living with HIV: a discrete choice experiment.
    J Acquir Immune Defic Syndr. 2022 Jul 21. pii: 00126334-990000000-00079.
    >> Share

    J Infect Dis

  44. TORIBIO M, Wilks MQ, Hedgire S, Lu MT, et al
    Increased Macrophage-Specific Arterial Infiltration Relates to Non-calcified Plaque and Systemic Immune Activation in People with HIV.
    J Infect Dis. 2022 Jul 20. pii: 6646962. doi: 10.1093.
    >> Share

  45. MAHANT A, Guerguis S, Blevins TP, Cheshenko N, et al
    Herpes Simplex Virus Glycoprotein D Antibodies Fail to Elicit Antibody-Dependent Cell-Mediated Cytotoxicity: Implications for Future Vaccines.
    J Infect Dis. 2022 Jul 14. pii: 6644507. doi: 10.1093.
    >> Share

    J Med Virol

  46. LAN J, Li W, Yu R, Syed F, et al
    Cell-to-cell transmission of HIV-1 from provirus-activated cells to resting naive and memory human primary CD4 T cells is highly efficient and requires CD4 and F-actin but not chemokine receptors.
    J Med Virol. 2022 Jul 15. doi: 10.1002/jmv.28005.
    >> Share

    J Virol

  47. MACEDO AB, Levinger C, Nguyen BN, Richard J, et al
    The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.
    J Virol. 2022 Jul 14:e0037222. doi: 10.1128/jvi.00372.
    >> Share

  48. BAKER EJ, Hughes K, Travieso T, Klotman ME, et al
    Establishment, Persistence, and Reactivation of Latent HIV-1 Infection in Renal Epithelial Cells.
    J Virol. 2022 Jul 5:e0062422. doi: 10.1128/jvi.00624.
    >> Share

  49. RATCLIFF AN, Venner CM, Olabode AS, Knapp J, et al
    Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope.
    J Virol. 2022 Jul 5:e0185121. doi: 10.1128/jvi.01851.
    >> Share

  50. WIETGREFE SW, Duan L, Anderson J, Marques G, et al
    Detecting Sources of Immune Activation and Viral Rebound in HIV Infection.
    J Virol. 2022 Jul 20:e0088522. doi: 10.1128/jvi.00885.
    >> Share


  51. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.
    Lancet. 2022;400:185-235.
    >> Share

  52. BOOTH A
    New HIV law welcomed in Argentina.
    Lancet. 2022;400:149.
    >> Share

    Lancet Infect Dis

  53. HENTZIEN M, Autran B, Piroth L, Yazdanpanah Y, et al
    A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab.
    Lancet Infect Dis. 2022 Jul 18. pii: S1473-3099(22)00495.
    >> Share

    MMWR Morb Mortal Wkly Rep

  54. TRAUB AM, Medley A, Gross J, Sloan M, et al
    Pediatric HIV Case Identification Across 22 PEPFAR-Supported Countries During the COVID-19 Pandemic, October 2019-September 2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:894-898.
    >> Share

    N Engl J Med

  55. THORNHILL JP, Barkati S, Walmsley S, Rockstroh J, et al
    Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.
    N Engl J Med. 2022 Jul 21. doi: 10.1056/NEJMoa2207323.
    >> Share

    PLoS One

  56. WOBESER WL, McBane JE, Balfour L, Conway B, et al
    A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infection.
    PLoS One. 2022;17:e0270590.
    >> Share

  57. SPENSLEY CB, Plegue M, Seda R, Harper DM, et al
    Annual HIV screening rates for HIV-negative men who have sex with men in primary care.
    PLoS One. 2022;17:e0266747.
    >> Share

  58. MATA-MARIN JA, de Pablos-Leal AA, Mauss S, Arroyo-Anduiza CI, et al
    Risk factors for HCV transmission in HIV-positive men who have sex with men in Mexico.
    PLoS One. 2022;17:e0269977.
    >> Share

  59. LUNGU P, Mushota K, Njelesani E, Sukwa T, et al
    Expression of mycobacterium tuberculosis induced SOCS3 and STAT3 and the implications on innate immunity in TB patients vs healthy contacts in high TB/HIV endemic setting: A cross-sectional analytical study.
    PLoS One. 2022;17:e0263624.
    >> Share

  60. WEMBABAZI A, Nassozi DR, Akot E, Ochola TI, et al
    Prevalence of Cryptococcus gattii in Ugandan HIV-infected patients presenting with cryptococcal meningitis.
    PLoS One. 2022;17:e0270597.
    >> Share

  61. ZIKO LM, Hoffman TW, Fwoloshi S, Chanda D, et al
    Aetiology and prognosis of community-acquired pneumonia at the Adult University Teaching Hospital in Zambia.
    PLoS One. 2022;17:e0271449.
    >> Share

  62. FREESTONE J, Siefried KJ, Prestage G, Hammoud M, et al
    Individual level peer interventions for gay and bisexual men who have sex with men between 2000 and 2020: A scoping review.
    PLoS One. 2022;17:e0270649.
    >> Share

  63. KUMAR P, Das C, Kumar A, Sahu D, et al
    Diversity in HIV epidemic transitions in India: An application of HIV epidemiological metrices and benchmarks.
    PLoS One. 2022;17:e0270886.
    >> Share

  64. HUNG CC, Banerjee S, Gilada I, Green K, et al
    Impact of COVID-19 on the HIV care continuum in Asia: Insights from people living with HIV, key populations, and HIV healthcare providers.
    PLoS One. 2022;17:e0270831.
    >> Share

  65. TESHA ED, Kishimba R, Njau P, Revocutus B, et al
    Predictors of loss to follow up from antiretroviral therapy among adolescents with HIV/AIDS in Tanzania.
    PLoS One. 2022;17:e0268825.
    >> Share

  66. NJUGUNA N, Mugo N, Anzala O, Mureithi M, et al
    An empiric tool to identify Kenyans living with HIV who will have unsuppressed viremia 18 months following treatment initiation to guide differentiated care models.
    PLoS One. 2022;17:e0271520.
    >> Share

  67. ABU-RADDAD LJ, Dargham S, Chemaitelly H, Coyle P, et al
    COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar.
    PLoS One. 2022;17:e0271324.
    >> Share

  68. WOLDESENBET S, Cheyip M, Lombard C, Manda S, et al
    Progress towards the UNAIDS 95-95-95 targets among pregnant women in South Africa: Results from the 2017 and 2019 national Antenatal HIV Sentinel Surveys.
    PLoS One. 2022;17:e0271564.
    >> Share

  69. GRACE D, Stewart M, Blaque E, Ryu H, et al
    Challenges to communicating the Undetectable equals Untransmittable (U=U) HIV prevention message: Healthcare provider perspectives.
    PLoS One. 2022;17:e0271607.
    >> Share

  70. QUINCER E, Philipsborn R, Morof D, Salzberg NT, et al
    Insights on the differentiation of stillbirths and early neonatal deaths: A study from the Child Health and Mortality Prevention Surveillance (CHAMPS) network.
    PLoS One. 2022;17:e0271662.
    >> Share

  71. DIRESS G, Adane S, Linger M, Merchaw A, et al
    Individual and community-level determinates of risky sexual behaviors among sexually active unmarried men: A multilevel analysis of 2016 Ethiopian Demographic and Health Survey.
    PLoS One. 2022;17:e0270083.
    >> Share

  72. MOUINGA-ONDEME A, Boundenga L, Koumba Koumba IP, Idam Mamimandjiami A, et al
    Human T-Lymphotropic virus type 1 and human immunodeficiency virus co-infection in rural Gabon.
    PLoS One. 2022;17:e0271320.
    >> Share

    PLoS Pathog

  73. STRONGIN Z, Hoang TN, Tharp GK, Rahmberg AR, et al
    The role of CD101-expressing CD4 T cells in HIV/SIV pathogenesis and persistence.
    PLoS Pathog. 2022;18:e1010723.
    >> Share

  74. MAJERCIAK V, Alvarado-Hernandez B, Lobanov A, Cam M, et al
    Genome-wide regulation of KSHV RNA splicing by viral RNA-binding protein ORF57.
    PLoS Pathog. 2022;18:e1010311.
    >> Share

    Proc Natl Acad Sci U S A

  75. SINGH AK, De Wijngaert B, Bijnens M, Uyttersprot K, et al
    Cryo-EM structures of wild-type and E138K/M184I mutant HIV-1 RT/DNA complexed with inhibitors doravirine and rilpivirine.
    Proc Natl Acad Sci U S A. 2022;119:e2203660119.
    >> Share

  76. WALKER-SPERLING V, Digitale JC, Viard M, Martin MP, et al
    Genetic variation that determines TAPBP expression levels associates with the course of malaria in an HLA allotype-dependent manner.
    Proc Natl Acad Sci U S A. 2022;119:e2205498119.
    >> Share

  77. CADA AK, Pavlin MR, Castillo JP, Tong AB, et al
    Friction-driven membrane scission by the human ESCRT-III proteins CHMP1B and IST1.
    Proc Natl Acad Sci U S A. 2022;119:e2204536119.
    >> Share


  78. CASAGRANDE TZ, Costa-Rocha IAD, Gavi MBRO, Miyamoto ST, et al
    Previous biological therapy and impairment of the IFN-gamma/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis.
    Vaccine. 2022 Jun 18. pii: S0264-410X(22)00703.
    >> Share


  79. ZHANG H, Deng T, Fang Q, Li S, et al
    Endodomain truncation of the HIV-1 envelope protein improves the packaging efficiency of pseudoviruses.
    Virology. 2022;574:1-8.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016